FSA compares two US equity products: the Morgan Stanley US Growth Fund and the T Rowe Price US Large Cap Growth Equity Fund.

FSA compares two US equity products: the Morgan Stanley US Growth Fund and the T Rowe Price US Large Cap Growth Equity Fund.
This week FSA presents a quick comparison of two US equities products: the MFS Meridian US Value Fund and the Morgan Stanley US growth Fund.
UOB loses; Value Partners gains; Amundi’s profits; Morgan Stanley’s JV; In defence of Abrdn; VanEck mines digital; Blackrock’s market cap dominance; advertising and much more.
UOB creates chief sustainability officer role; Natixis IM appoints new CEO; Barings hires for institutional distribution; T Rowe Price names Apac operating officer; and more…
Leon Sun was Nomura Asset Management’s head of investment for China and Hong Kong.
BNY Mellon IM creates Greater China head of intermediary role; T Rowe Price hires from Gam; Morgan Stanley IM names Apac (ex-Japan) marketing head; and more…
The top 10 most read Head-to-Head articles for 2020 mostly included a variety of global and regional equity and fixed income products.
The strong performing product aims to complement a similar global equity opportunities fund.
MSIM is also nearing full ESG integration, with around 80% of its AUM integrating ESG factors or applying ESG exclusionary screens.
China goes negative; BNP Paribas’ Energy; Is the market overvalued; Standard Life Aberdeen and ETFs; FSMOne’s risk; Central Bank madness; Cash; RWC’s charity and much more.
Part of the Mark Allen Group.